Filter
153
Filtered Results: 153
Text search:
Burri,
C.
Featured
Recommendations
17
New Publications
29
Language
Document type
No document type
99
Studies & Reports
21
Guidelines
18
Strategic & Response Plan
8
Manuals
6
Infographics
1
Countries / Regions
Indonesia
39
Africa
8
East and Southern Africa
6
Global
5
West and Central Africa
5
Uganda
5
Germany
4
India
4
Middle East and North Africa
3
Eastern Europe
3
Ukraine
2
Sierra Leone
2
Malawi
2
Zimbabwe
2
Mozambique
2
Tanzania
2
Spain
2
Vietnam
2
Russia
2
South Sudan
2
Tajikistan
1
Kenya
1
Turkey
1
Ghana
1
Rwanda
1
Nigeria
1
Burundi
1
Peru
1
Italy
1
Asia
1
Latin America and the Carribbean
1
Congo, Democratic Republic of
1
Western and Central Europe
1
Paraguay
1
France
1
United Kingdom
1
Portugal
1
Bangladesh
1
South Africa
1
Brazil
1
Namibia
1
Ethiopia
1
Angola
1
Zambia
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Humanitarian Crisis
39
Studies & Reports
7
Surgery & Anaesthesia
6
HIV & STI
6
COVID-19
5
Policies
4
Guidelines
4
Drugs & Medical Equipment
4
Reproductive Health
4
Family Planning
3
Clinical Guidelines
3
Paediatrics
2
Hepatitis
2
Diabetes
2
Pediatrics
2
Disabilities
2
Capacity Building
2
Communicable Diseases
1
Disaster Preparedness
1
Community Health
1
COVID-19
1
Virology
1
Countries
1
Cardiovascular Diseases
1
Medical Devices & Equipment
1
Policies & Guidelines HIV & TB
1
Information, Education and Communication (IEC)
1
WASH
1
Immunization
1
General Guidelines
1
Gynaecology & Obstetrics
1
Maternal Health
1
Human African Trypanosomiasis
1
Disease Prevention & Control
1
Pharmacy & Technologies
1
Hygiene Promotion
1
Food Security & Nutrition
1
Toolboxes
TB & Drug Abuse
6
Clinical Aspects & Diagnostics
6
Studies & Reports
6
Clinical Guidelines
4
Country specific documents
4
Essential Medicines
4
Treatment & Prevention
3
Opportunistic Infections
3
Women & Maternal Health
3
War Surgery & Wound Care
3
Children & Adolescents
2
Introduction to Global Health
2
Context, Facts & Travel Advice
2
Human Rights
2
Mental Health Guidelines
2
Prevention & Preparedness
2
Non-pharmaceutical interventions (NPIs)
2
Essential Medicines & Devices Lists
2
Rational use of Medicine
2
Surgery
2
Non-communicable Diseases NCD
2
General Information & Methodology
2
Substance Use Disorders & Addiction
2
Human Rights & the Right to Health
2
TB/HIV Coinfection
2
Drugs
1
Outbreak Prevention & Control
1
Policies & Strategies
1
Integration
1
Assessment & Studies
1
Meningitis Prevention & Control
1
Local Action
1
Accessibility
1
Background PTSD in children
1
Clinical Aspects, Treatment & Prevention
1
Clinical Aspects
1
Surgery & Rehabilitation
1
Policies & Programmes
1
Substance Use Disorders, Others
1
Germany
1
Social Worker
1
Public Health
1
Concepts of Global Health
1
Curricula & Core Competencies
1
Communication & Training
1
Germany
1
HIV
1
General Studies & Reports
1
Mental Health
1
Cholera Prevention & Control
1
People who injecting Drugs
1
Rwanda
1
Health & Refugee
1
Discrimination & Stigma
1
Posttraumatic Stress Disorder in Children
1
Medical professionals
1
Situation Reports & Updates
1
Clinical Aspects
1
Public Health
1
Training, others
1
Appeals and Response Plans
1
Physical Distancing
1
Vaccine Candidates & Research
1
TB/HIV
1
SARS-CoV-2 Variants
1
Prices and Patents
1
Pharmacy Management
1
Traditional & Herbal Medicines
1
General Guidelines for Rational Use
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
Global Overview
1
General
1
Co-Morbidities (except TB)
1
Clinical Guidelines
1
Hearing Loss & Deafness
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
General
1
Prevention of mother-to-child transmission (PMTCT)
1
Vision Loss & Blindness
1
Antiretroviral Treatment ART
1
Safe Burials
1
Prisoners
1
Reports & Studies
1
Neurological disorders, Others
1
Eastern Europe and central Asia
1
Key populations brief.
Краткое руководство
Background: Traumatic stress may arise from various incidents often leading to posttraumatic stress disorder (PTSD). The lifetime prevalence of PTSD is estimated at 1% – 2% in Western Europe, 6% – 9% in North America and at just over 10% in countries exposed to long-term
violence. In South Afri...
What are the local beliefs and practices around illnesses and death, the transmission of disease and spirituality, which affect decision-making (around health-seeking behaviour, caring for relatives and nature of burials) and can inform effective behaviour change interventions for preventing Ebola i...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
The twentieth century ended with human African trypanosomiasis (HAT) epidemics raging across many parts of Africa. Resistance to existing drugs was emerging, and many programs aiming to contain the disease had ground to a halt, given previous success against HAT and the competing priorities associat...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
